A newly approved breast cancer drug is offering hope and more time to patients with advanced, incurable disease. The pill, called capivasertib, is now being funded by the NHS in England and has already helped some women live years longer than expected. One patient, Linda Kelly, credits the treatment with giving her nearly four extra years to travel, garden, and plan new adventures. The drug works by targeting a protein that fuels cancer growth, slowing disease progression and reducing the need for chemotherapy.
In clinical trials, capivasertib significantly delayed cancer growth and shrank tumors in nearly a quarter of patients. Experts say it’s one of the most effective advanced cancer drugs they’ve seen and a major step forward in targeted therapy. For thousands of patients, this pill means not just more time—but a better quality of life.